{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:53:07Z","timestamp":1781646787543,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82301374"],"award-info":[{"award-number":["82301374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hubei Provincial Natural Science Foundation and Xiangyang of China","award":["2025AFD068"],"award-info":[{"award-number":["2025AFD068"]}]},{"name":"the Institute of Neuroscience and Brain Science, Affiliated Hospital of Hubei University of Arts and Science","award":["2023NBI07"],"award-info":[{"award-number":["2023NBI07"]}]},{"name":"the project of Xiangyang Central Hospital","award":["2024BS03"],"award-info":[{"award-number":["2024BS03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      May-Hegglin anomaly, a rare autosomal dominant disorder caused by\n                      <jats:italic>MYH9<\/jats:italic>\n                      mutations, is characterized by the classic \"triad\" of thrombocytopenia, giant platelets, and granulocyte cytoplasmic inclusion bodies; some patients also present non-hematological symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We reported a family of\n                      <jats:italic>MYH9<\/jats:italic>\n                      -related disease. The proband had microscopic hematuria, proteinuria, and thrombocytopenia on physical examination; blood smear re-examination showed giant platelets and D\u00f6hle-like bodies. His medical history included childhood epistaxis; his father had unexplained thrombocytopenia\/proteinuria, and his younger brother had epistaxis\/purpura\/thrombocytopenia. Whole-exome sequencing (validated by Sanger sequencing) confirmed the diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Diagnosis of\n                      <jats:italic>MYH9<\/jats:italic>\n                      -related diseases depends on combined laboratory morphology and molecular biology. Routine blood tests and smear microscopy (identifying abnormal giant platelets\/D\u00f6hle-like bodies) provide initial screening clues, while gene sequencing enables accurate diagnosis and pathogenesis clarification, forming a complete screening-to-confirmation diagnostic pathway.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-026-02347-0","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:35:26Z","timestamp":1774683326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case report of a family with MYH9 gene mutation-related disease in an ethnic minority group and literature review"],"prefix":"10.1186","volume":"19","author":[{"given":"Xia","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Ting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"8","key":"2347_CR1","first-page":"e16964","volume":"13","author":"A Thurlapati","year":"2021","unstructured":"Thurlapati A, Guntupalli S, Mansour R. Myosin Heavy Chain 9 (MYH9)-Related Congenital Macrothrombocytopenia. Cureus. 2021;13(8):e16964.","journal-title":"Cureus"},{"issue":"2","key":"2347_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1182\/blood-2002-09-2783","volume":"102","author":"S Deutsch","year":"2003","unstructured":"Deutsch S, Rideau A, Bochaton-Piallat ML, Merla G, Geinoz A, Gabbiani G, et al. Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly\/Fechtner syndrome. Blood. 2003;102(2):529\u201334.","journal-title":"Blood"},{"issue":"1","key":"2347_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/79063","volume":"26","author":"M Seri","year":"2000","unstructured":"Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C, et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. Nat Genet. 2000;26(1):103\u20135.","journal-title":"Nat Genet"},{"issue":"2","key":"2347_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood.V65.2.397.397","volume":"65","author":"LC Peterson","year":"1985","unstructured":"Peterson LC, Rao KV, Crosson JT, White JG. Fechtner syndrome--a variant of Alport\u2019s syndrome with leukocyte inclusions and macrothrombocytopenia. Blood. 1985;65(2):397\u2013406.","journal-title":"Blood"},{"issue":"1","key":"2347_CR5","first-page":"63","volume":"5","author":"MR Balwani","year":"2016","unstructured":"Balwani MR, Engineer DP, Gumber MR, Kute VB, Singh R, Patel HV, et al. An unusual cause of renal failure; Epstein syndrome. J Nephropharmacol. 2016;5(1):63\u20135.","journal-title":"J Nephropharmacol"},{"issue":"6","key":"2347_CR6","doi-asserted-by":"publisher","first-page":"102552","DOI":"10.1016\/j.rpth.2024.102552","volume":"8","author":"K Shen","year":"2024","unstructured":"Shen K, Chen T, Xiao M. MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches. Res Pract Thromb Haemost. 2024;8(6):102552.","journal-title":"Res Pract Thromb Haemost"},{"issue":"8","key":"2347_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/qjmed\/hcae081","volume":"117","author":"S Okuyama","year":"2024","unstructured":"Okuyama S, Ueki T, Tanaka K, Tajima K. MYH9-related disease misdiagnosed for a decade: lessons from diagnostic pitfalls. QJM. 2024;117(8):615\u20136.","journal-title":"QJM"},{"issue":"1","key":"2347_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s13730-024-00892-0","volume":"14","author":"Y Horibe","year":"2025","unstructured":"Horibe Y, Yamanaka K, Kaimori J, Miyata Y, Fukae S, Yoshida T, et al. MYH9-related disorder with sole presentation of end-stage kidney disease and long-term, recurrence-free living after living donor renal transplantation: a case report. CEN Case Rep. 2025;14(1):11\u20135.","journal-title":"CEN Case Rep"},{"key":"2347_CR9","doi-asserted-by":"publisher","first-page":"2050313X2413020","DOI":"10.1177\/2050313X241302013","volume":"12","author":"MD Nguyen","year":"2024","unstructured":"Nguyen MD, Dileep G, Quizon M, Nguyen V, Demerci A, Hanna R. May-hegglin anomaly associated nephropathy: case series. SAGE Open Med Case Rep. 2024;12:2050313X241302013.","journal-title":"SAGE Open Med Case Rep"},{"issue":"3","key":"2347_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3109\/09537104.2015.1064882","volume":"27","author":"E Zetterberg","year":"2016","unstructured":"Zetterberg E, Carlsson Alle MS, Najm J, Greinacher A. Thrombin generation in two families with MYH9-related platelet disorder. Platelets. 2016;27(3):264\u20137.","journal-title":"Platelets"},{"issue":"7","key":"2347_CR11","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1515\/cclm-2017-0813","volume":"56","author":"X Guo","year":"2018","unstructured":"Guo X, Lian X, Zhang W, Hao J. A D1424N mutation in the MYH9 gene results in macrothrombocytopenia and granulocytic inclusion bodies in a Chinese inherited macrothrombocytopenia pedigree. Clin Chem Lab Med. 2018;56(7):e171\u20133.","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"2347_CR12","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1097\/MPH.0000000000000379","volume":"37","author":"S Okano","year":"2015","unstructured":"Okano S, Takase M, Iseki K, Toriumi N, Kaneda M, Kunishima S. Genotype-phenotype correlation of the p.R1165C mutation in the MYH9 disorder: report of a Japanese pedigree. J Pediatr Hematol Oncol. 2015;37(6):e352-355.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"15","key":"2347_CR13","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1182\/bloodadvances.2022008011","volume":"6","author":"Y Cao","year":"2022","unstructured":"Cao Y, Sun Y, Deng Y, Wei G, Liu J, Jin S, et al. Defective VWF secretion due to expression of MYH9-RD E1841K mutant in endothelial cells disrupts hemostasis. Blood Adv. 2022;6(15):4537\u201352.","journal-title":"Blood Adv"},{"issue":"7","key":"2347_CR14","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00277-011-1370-5","volume":"91","author":"J Hao","year":"2012","unstructured":"Hao J, Kunishima S, Guo X, Hu R, Gao W. A large family with MYH9 disorder caused by E1841K mutation suffering from serious kidney and hearing impairment and cataracts. Ann Hematol. 2012;91(7):1147\u20138.","journal-title":"Ann Hematol"},{"key":"2347_CR15","doi-asserted-by":"publisher","first-page":"1588675","DOI":"10.3389\/fped.2025.1588675","volume":"13","author":"X Lian","year":"2025","unstructured":"Lian X, Li H, Hao J, Li H, Xu L, Zhang S, et al. Case report: a Chinese family with MYH9-RD caused by MYH9 p.E1841K mutation exhibiting widespread may-hegglin inclusions. Front Pediatr. 2025;13:1588675.","journal-title":"Front Pediatr"},{"issue":"26","key":"2347_CR16","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1182\/blood-2010-08-304725","volume":"116","author":"A Pecci","year":"2010","unstructured":"Pecci A, Gresele P, Klersy C, Savoia A, Noris P, Fierro T, et al. Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations. Blood. 2010;116(26):5832\u20137.","journal-title":"Blood"},{"issue":"6","key":"2347_CR17","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ajh.25472","volume":"94","author":"AS Smith","year":"2019","unstructured":"Smith AS, Pal K, Nowak RB, Demenko A, Zaninetti C, Da Costa L, et al. MYH9-related disease mutations cause abnormal red blood cell morphology through increased myosin-actin binding at the membrane. Am J Hematol. 2019;94(6):667\u201377.","journal-title":"Am J Hematol"},{"issue":"8","key":"2347_CR18","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1080\/09537104.2022.2096211","volume":"33","author":"AR Arif","year":"2022","unstructured":"Arif AR, Zhao M, Chen W, Xue M, Luo S, Wang Y. Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure. Platelets. 2022;33(8):1307\u201311.","journal-title":"Platelets"},{"issue":"2","key":"2347_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1160\/TH07-09-0568","volume":"99","author":"P Nurden","year":"2008","unstructured":"Nurden P, Nurden AT. Congenital disorders associated with platelet dysfunctions. Thromb Haemost. 2008;99(2):253\u201363.","journal-title":"Thromb Haemost"},{"issue":"2","key":"2347_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2141.2011.08716.x","volume":"154","author":"CL Balduini","year":"2011","unstructured":"Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Haematol. 2011;154(2):161\u201374.","journal-title":"Br J Haematol"},{"issue":"6","key":"2347_CR21","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1159\/000452597","volume":"41","author":"L Liu","year":"2016","unstructured":"Liu L, Wang C, Mi Y, Liu D, Li L, Fan J, et al. Association of MYH9 polymorphisms with hypertension in patients with chronic kidney disease in China. Kidney Blood Press Res. 2016;41(6):956\u201365.","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"2347_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s13730-023-00786-7","volume":"12","author":"M Nakamura","year":"2023","unstructured":"Nakamura M, Miura K, Shirai Y, Ishizuka K, Nakamura T, Segawa O, et al. Successful administration of eltrombopag in preparation for peritoneal dialysis catheter placement in a girl with MYH9-related disease. CEN Case Rep. 2023;12(4):419\u201322.","journal-title":"CEN Case Rep"},{"issue":"1","key":"2347_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/humu.23927","volume":"41","author":"L Bury","year":"2020","unstructured":"Bury L, Megy K, Stephens JC, Grassi L, Greene D, Gleadall N, et al. Next-generation sequencing for the diagnosis of MYH9-RD: predicting pathogenic variants. Hum Mutat. 2020;41(1):277\u201390.","journal-title":"Hum Mutat"},{"issue":"2","key":"2347_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000342123","volume":"129","author":"XH Sun","year":"2013","unstructured":"Sun XH, Wang ZY, Yang HY, Cao LJ, Su J, Yu ZQ, et al. Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease. Acta Haematol. 2013;129(2):106\u201313.","journal-title":"Acta Haematol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-026-02347-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02347-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02347-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:02:46Z","timestamp":1781643766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-026-02347-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2347"],"URL":"https:\/\/doi.org\/10.1186\/s12920-026-02347-0","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with the Declaration of Helsinki and all applicable ethical guidelines. Written informed consent to participate has been obtained from all the participants and the parents\/legal guardians of minors. The present study was conducted based on findings from clinical blood smears and results of whole-exome sequencing (WES) to identify gene variations. This study was approved by the research ethics board of Xiangyang Central Hospital affiliated hospital of Hubei University of Arts and Science (No. 2025-063).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent has been obtained from all the participants and the legal guardians of minors for publication of clinical details and clinical images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}